Potentiation of Glucocorticoid Receptor Transcriptional Activity by Sumoylation
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The glucocorticoid receptor (GR) is a transcription factor, subject to several types of posttranslational modifications including phosphorylation and ubiquitination. We showed that the GR is covalently modified by the small ubiquitin-related modifier-1 (SUMO-1) peptide in mammalian cells. We demonstrated that GR sumoylation is not dependent on the presence of the ligand and regulates the stability of the protein as well as its transcriptional activity. SUMO-1 overexpression induces dramatic GR degradation, abolished by proteasome inhibition. We also found that SUMO-1 stimulates the transactivation capacity of GRs to an extent largely exceeding those observed so far for other sumoylated transcription factors. Overexpression of SUMO-1 specifically enhances the ligand-induced transactivation of GR up to 8-fold. However, this hyperactivation occurs only in the context of a synergy between multiple molecules of GRs. It requires more than one receptor DNA-binding site in promoter and becomes more prominent as the number of sites increases. Interestingly, these observations may be related to the transcriptional properties of the synergy control region of GRs, which precisely contains two evolutionary conserved sumoylation sites. We propose a model in which SUMO-1 regulates the synergy control function of GR and serves as a unique signal for activation and destruction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sumoylation of GRα has been shown to promote its degradation and inhibits the transcriptional activity of GR in a promoter-specific manner by recruiting corepressors81.”
From Corticosteroids (2016) · cites this paper as [81]
In the citing paper
“GR is sumoylated at residues Lys-277, Lys-293 and Lys-703 (Fig.3B).”
From Corticosteroids (2016) · cites this paper as [81]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 895
The glucocorticoid receptor: rapid exchange with regulatory sites in living cells
McNally, J. G., Müller, W. G., Walker, D., Wolford, R., & Hager, G. L. (2000) · Science · doi:10.1126/science.287.5456.1262 · Cited by 802
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 510
Ubiquitin-like proteins: new wines in new bottles
Yeh, E. T. H., Gong, L., & Kamitani, T. (2000) · Gene · doi:10.1016/s0378-1119(00)00139-6 · Cited by 469
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity
Schmidt, D., & Müller, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052559499 · Cited by 448
c-Jun and p53 Activity Is Modulated by SUMO-1 Modification
Müller, S., Berger, M., Lehembre, F., Seeler, J.-S., Haupt, Y., & Dejean, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13321 · Cited by 400
Wallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394
Covalent Modification of p73α by SUMO-1
Minty, A., Dumont, X., Kaghad, M., & Caput, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004293200 · Cited by 388
Regulation of p53 activity in nuclear bodies by a specific PML isoform
Fogal, V. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6185 · Cited by 372
Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification
Hong, Y., Rogers, R., Matunis, M. J., Mayhew, C. N., Goodson, M., Park-Sarge, O.-K., & Sarge, K. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104714200 · Cited by 266
Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B., & Tansey, W. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3118 · Cited by 261
Transcriptional regulation by steroid hormones
Beato, M., Chávez, S., & Truss, M. (1996) · Steroids · doi:10.1016/0039-128x(96)00030-x · Cited by 259
Iñiguez-Lluhí, J. A., & Pearce, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6040-6050.2000 · Cited by 217
Bies, J., Markus, J., & Wolff, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110453200 · Cited by 182
Kotaja, N. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.1986 · Cited by 175
Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription
Poukka, H., Aarnisalo, P., Karvonen, U., Palvimo, J. J., & Jänne, O. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19441 · Cited by 174
Glucocorticoid signalling—multiple variations of a common theme
Reichardt, H. M., & Schütz, G. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00208-1 · Cited by 171
Molecular Mechanisms of Glucocorticosteroid Actions
Adcock, I. M. (2000) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2000.0243 · Cited by 158
SUMO-1: wrestling with a new ubiquitin-related modifier
Saitoh, H., Pu, R. T., & Dasso, M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01102-x · Cited by 144
Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence
Bodwell, J. E., Webster, J. C., Jewell, C. M., Cidlowski, J. A., Hu, J.-M., & Munck, A. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00185-4 · Cited by 138
Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor Levels
Sheflin, L. G., Keegan, B. P., Zhang, W., & Spaulding, S. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3424 · Cited by 131
SUMO conjugation and deconjugation
Schwienhorst, I., Johnson, E. S., & Dohmen, R. J. (2000) · Molecular and General Genetics MGG · doi:10.1007/s004380000254 · Cited by 128
Role of Acidic and Phosphorylated Residues in Gene Activation by the Glucocorticoid Receptor
Almlöf, T., Wright, A. P. H., & Gustafsson, J.-Å. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17535 · Cited by 107
Intracellular Targeting of Proteins by Sumoylation
Wilson, V. G., & Rangasamy, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5366 · Cited by 105
Baumann, C. T. (2001) · Molecular Endocrinology · doi:10.1210/me.15.4.485 · Cited by 95
Transcriptional regulation: Kamikaze activators
Thomas, D., & Tyers, M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00462-0 · Cited by 94
Dréan, Y. L., Kern, L., Pakdel, F., & Valotaire, Y. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03482-m · Cited by 90
Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors
Kaul, S., Blackford, J. A., Cho, S., & Simons, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112330200 · Cited by 83
Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor
Göttlicher, M., Heck, S., Doucas, V., Wade, E. J., Kullmann, M. K., Cato, A. C. B., Evans, R. M., & Herrlich, P. A. (1996) · Steroids · doi:10.1016/0039-128x(96)00032-3 · Cited by 76
Kotaja, N., Vihinen, M., Palvimo, J. J., & Jänne, O. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106354200 · Cited by 62
Jin, C., Shiyanova, T., Shen, Z., & Liao, X. (2001) · International Journal of Biological Macromolecules · doi:10.1016/s0141-8130(00)00169-0 · Cited by 31
Cited by
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
“Strikingly, mutation of the SUMO acceptor site in GR or overexpression of SUMO-1 has been shown to increase activity from some GR target promoters but not others (Le Drean et al. 2002; Tian et al. 2002; Holmstrom et al. 2003).”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Metadata
- Authors
- Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Michel, Denis
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-09
- Volume
- 143
- Issue
- 9
- Pages
- 3482-3489
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2007938731
- Cited by
- 159
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 10 · 2012: 8
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- glucocorticoid receptor, SUMOylation, SUMO1, transcriptional activation, protein stability, proteasomal degradation, post-translational modification, transcription factor regulation
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, DNA, Drug Stability, Drug Synergism, Cricetinae, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Fusion Proteins, Structure-Activity Relationship, Transcription, Genetic, Transfection, Transcriptional Activation, Gene Expression, Sequence Alignment, CHO Cells, COS Cells, SUMO-1 Protein, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.